Literature DB >> 23222359

The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons.

Bassil Hassan1, Victor Ruiz-Velasco.   

Abstract

BACKGROUND AND OBJECTIVES: κ-Opioid receptor (κ-OR) activation is known to play a role in analgesia and central sedation. The purpose of the present study was to examine the effect of the κ-OR agonist, U-50488 (an arylacetamide), on Ca channel currents and the signaling proteins involved in acutely isolated rat dorsal root ganglion (DRG) neurons expressing the putative promoter region of the tetrodotoxin-resistant Na channel (NaV 1.8) that is known to be involved in pain transmission.
METHODS: Acutely isolated rat DRG neurons were transfected with cDNA coding for enhanced green fluorescent protein (EGFP), whose expression is driven by the NaV 1.8 promoter region. Thereafter, the whole-cell variant of the patch-clamp technique was used to record Ca channel currents in neurons expressing EGFP.
RESULTS: Exposure of EGFP-expressing DRG neurons to U-50488 (0.3-40 μM) led to voltage-independent inhibition of the Ca channel currents. The modulation of the Ca currents did not appear to be mediated by the Gα protein subfamilies: Gαi/o, Gαs, Gαq/11, Gα14, and Gαz. Furthermore, dialysis of the hydrolysis-resistant GDP analog, GDP-β-S (1 mM), did not affect the U-50488-mediated blocking effect, ruling out involvement of other G protein subunits. Finally, U-50488 (20 μM) blocked Ca channels heterologously expressed in HeLa cells that do not express κ-OR.
CONCLUSION: These results suggest that the antinociceptive actions mediated by U-50488 are likely due to both a direct block of Ca channels in sensory neurons as well as G protein modulation of Ca currents via κ-OR-expressing neurons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23222359      PMCID: PMC3530143          DOI: 10.1097/AAP.0b013e318274a8a1

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  24 in total

Review 1.  The role of kappa-opioid receptor activation in mediating antinociception and addiction.

Authors:  Yu-hua Wang; Jian-feng Sun; Yi-min Tao; Zhi-qiang Chi; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

2.  Double-pulse calcium channel current facilitation in adult rat sympathetic neurones.

Authors:  S R Ikeda
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

3.  Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons.

Authors:  L Sangameswaran; S G Delgado; L M Fish; B D Koch; L B Jakeman; G R Stewart; P Sze; J C Hunter; R M Eglen; R C Herman
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

4.  Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.

Authors:  F Simonin; O Valverde; C Smadja; S Slowe; I Kitchen; A Dierich; M Le Meur; B P Roques; R Maldonado; B L Kieffer
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

5.  A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons.

Authors:  A N Akopian; L Sivilotti; J N Wood
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

6.  The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells.

Authors:  M Tallent; M A Dichter; G I Bell; T Reisine
Journal:  Neuroscience       Date:  1994-12       Impact factor: 3.590

7.  Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by kappa-opioids.

Authors:  J M Gschossmann; V V Chaban; J A McRoberts; H E Raybould; S H Young; H S Ennes; T Lembo; E A Mayer
Journal:  Brain Res       Date:  2000-02-21       Impact factor: 3.252

8.  The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.

Authors:  Xin Su; Neil A Castle; Brett Antonio; Rosemarie Roeloffs; James B Thomas; Douglas S Krafte; Mark L Chapman
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

9.  An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.

Authors:  M K Pugsley; D A Saint; M J Walker
Journal:  Eur J Pharmacol       Date:  1994-08-22       Impact factor: 4.432

10.  Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.

Authors:  Allen W Mangel; Gareth A Hicks
Journal:  Clin Exp Gastroenterol       Date:  2012-01-12
View more
  6 in total

1.  Identification of CaV channel types expressed in muscle afferent neurons.

Authors:  Renuka Ramachandra; Bassil Hassan; Stephanie G McGrew; James Dompor; Mohamed Farrag; Victor Ruiz-Velasco; Keith S Elmslie
Journal:  J Neurophysiol       Date:  2013-07-10       Impact factor: 2.714

2.  A 3.7 kb fragment of the mouse Scn10a gene promoter directs neural crest but not placodal lineage EGFP expression in a transgenic animal.

Authors:  Van B Lu; Stephen R Ikeda; Henry L Puhl
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

3.  Alteration of the mu opioid receptor: Ca2+ channel signaling pathway in a subset of rat sensory neurons following chronic femoral artery occlusion.

Authors:  Bassil Hassan; Joyce S Kim; Mohamed Farrag; Marc P Kaufman; Victor Ruiz-Velasco
Journal:  J Neurophysiol       Date:  2014-09-17       Impact factor: 2.714

4.  Characterization of the Presence and Function of Platelet Opioid Receptors.

Authors:  Sarah M Gruba; Danielle H Francis; Audrey F Meyer; Eleni Spanolios; Jiayi He; Ben M Meyer; Donghyuk Kim; Kang Xiong-Hang; Christy L Haynes
Journal:  ACS Meas Sci Au       Date:  2021-08-24

5.  The differential effects of a selective kappa-opioid receptor agonist, U50488, in guinea pig heart tissues.

Authors:  Chi-Feng Hung; Hsin-Ju Li; Hsun-Hao Chang; Gon-Ann Lee; Ming Jai Su
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

6.  Evaluation of Antinociceptive Effects of Chitosan-Coated Liposomes Entrapping the Selective Kappa Opioid Receptor Agonist U50,488 in Mice.

Authors:  Liliana Mititelu Tartau; Maria Bogdan; Beatrice Rozalina Buca; Ana Maria Pauna; Cosmin Gabriel Tartau; Lorena Anda Dijmarescu; Eliza Gratiela Popa
Journal:  Medicina (Kaunas)       Date:  2021-02-04       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.